University of Washington

Blood and lymphatic vessel invasion in pT1 colorectal cancer: An international concordance study () Kojima M, Puppa G, Kirsch R, Basturk O, Frankel WL, Vieth M, Lugli A, et al. Journal article Crosstalk of injured podocytes with parietal epithelial cells through Wnt4/β-Catenin signaling (2025) Schwartze E, Pfister E, Endlich N, Endlich T, Amann KU, Büttner-Herold M, Pippin J, et al. Journal article Scientists’ mental models of microplastics: insights into expert perceptions from an exploratory comparison of research methods (2025) Bostrom A, van den Broek KL, Böhm G, Grünzner M, Felipe-Rodriguez M, Fian L, Stevens S, et al. Journal article MEIS1::NCOA1 Primitive Spindle Cell Sarcoma of the Kidney: Report of 7 Cases of a Distinctive Clinicopathologic Entity (2025) Argani P, Wangsiricharoen S, Tretiakova M, Liu YJ, Falzarano SM, Collins K, Brimo F, et al. Journal article Inflammatory cytokine upd3 induces axon length–dependent synapse removal by glia (2025) Tenedini FM, Yin C, Huang JM, Dhiman N, Soba P, Parrish JZ Journal article Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials (2025) Lee MM, Sattar N, Pop-Busui R, Deanfield J, Emerson SS, Inzucchi SE, Mann JF, et al. Journal article Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial (2025) Mahaffey KW, Tuttle KR, Arici M, Baeres FM, Bakris G, Charytan DM, Cherney DZ, et al. Journal article Community estimate of global glacier mass changes from 2000 to 2023 (2025) Zemp M, Jakob L, Dussaillant I, Nussbaumer SU, Gourmelen N, Dubber S, A G, et al. Journal article Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6 (2025) Apperloo EM, Cherney DZ, Kuhlman AB, Mann JF, Rasmussen S, Rossing P, Tuttle KR, et al. Journal article A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial (2025) Hortobagyi GN, Lacko A, Sohn J, Cruz F, Ruiz Borrego M, Manikhas A, Hee Park Y, et al. Journal article